Is CNS Pharmaceuticals Inc (CNSP) overvalued? · $6.6M cap
CNS Pharmaceuticals Inc (CNSP) is a biotechnology company listed on NASDAQ.
This page asks whether CNS Pharmaceuticals Inc (CNSP) looks expensive on cached numbers — not a short thesis.
No cached income statement for CNSP, so there is no earnings base to call rich or cheap.
CNSP currently screens at market cap $6.6M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CNSP 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CNSP stock page for the full model, not this heading.
Not investment advice.